[1] |
DRAKE M T, CLARKE B L, LEWIECKI E M. The pathophysiology and treatment of osteoporosis[J]. Clin Ther, 2015, 37(8):1837-1850.
|
[2] |
BOYLE W J, SIMONET W S, LACEY D L. Osteoclast differentiation and activation[J]. Nature, 2003, 423(6937):337-342.
|
[3] |
刘庆羊, 孙自强,赵鸿雁,等. 自噬在骨保护素对破骨细胞及其前体凋亡过程的调控机制[J]. 畜牧兽医学报, 2018, 49(8):1761-1769.
|
|
LIU Q Y, SUN Z Q, ZHAO H Y, et al. Effects of autophagy on the apoptosis of osteoclasts and osteoclast precursors mediated by Osteoprotegerin[J]. Acta Veterinaria et Zootechnica Sinica, 2018, 49(8):1761-1769. (in Chinese)
|
[4] |
KALYANARAMAN H, RAMDANI G, JOSHUA J, et al. A novel, direct no donor regulates osteoblast and osteoclast functions and increases bone mass in ovariectomized mice[J]. J Bone Miner Res, 2017, 32(1):46-59.
|
[5] |
YANG Y H, ZHENG X F, LI B, et al. Increased activity of osteocyte autophagy in ovariectomized rats and its correlation with oxidative stress status and bone loss[J]. Biochem Biophys Res Commun, 2014, 451(1):86-92.
|
[6] |
DESELM C J, MILLER B C, ZOU W, et al. Autophagy proteins regulate the secretory component of osteoclastic bone resorption[J]. Dev Cell, 2011, 21(6):1179.
|
[7] |
ZHAO H F, LI X M, LI N, et al. Long-term resveratrol treatment prevents ovariectomy-induced osteopenia in rats without hyperplastic effects on the uterus[J]. Br J Nutr, 2014, 111(5):836-846.
|
[8] |
KNEISSEL M, LUONG-NGUYEN N H, BAPTIST M, et al. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts[J]. Bone, 2004, 35(5):1144-1156.
|
[9] |
LEVINE B, KROEMER G. Autophagy in the pathogenesis of disease[J]. Cell, 2008, 132(1):27-42.
|
[10] |
PHILIPPE C, PINSON B, DOMPIERRE J, et al. AICAR antiproliferative properties involve the AMPK-independent activation of the tumor suppressors LATS 1 and 2[J]. Neoplasia, 2018, 20(6):555-562.
|
[11] |
ZHOU G, SEBHAT I K, ZHANG B B. AMPK activators-potential therapeutics for metabolic and other diseases[J]. Acta Physiol, 2009, 196(1):175-190.
|
[12] |
DONG W, QI M C, WANG Y R, et al. Zoledronate and high glucose levels influence osteoclast differentiation and bone absorption via the AMPK pathway[J]. Biochem Biophys Res Commun, 2018, 505(4):1195-1202.
|
[13] |
LEE Y S, KIM Y S, LEE S Y, et al. AMP kinase acts as a negative regulator of RANKL in the differentiation of osteoclasts[J]. Bone, 2010, 47(5):926-937.
|
[14] |
高柳,刘慧新. AMP活化蛋白激酶通路对骨重建影响的研究现状[J]. 河北医科大学学报, 2014, 35(9):1108-1113.
|
|
GAO L, LIU H X. Current research on the effect of AMP-activated protein kinase pathway on bone reconstruction[J]. Journal of Hebei Medical University, 2014, 35(9):1108-1113. (in Chinese)
|
[15] |
QUINN J M W, TAM S, SIMS N A, et al. Germline deletion of AMP-activated protein kinase β subunits reduces bone mass without altering osteoclast differentiation or function[J]. FASEB J, 2010, 24(1):275-285.
|
[16] |
GENANT H. 雷尼酸锶预防绝经后妇女的骨流失[C]//2007国际骨质疏松——骨与关节大会论文集. 北京:中华医学会骨科学分会,中国健康促进基金会, 2007. (in English) GENANT H. Prevention of bone loss in the postmenopausal woman with strontium ranelate[C]//2007 international osteoporosis conference. Beijing:Chinese Orthopaedic Association of Chinese Medical Association, China Health Promotion Foundation, 2007.
|
[17] |
CHUN M J, CHOI H, JUN D W, et al. Fanconi anemia protein FANCD2 is activated by AICAR, a modulator of AMPK and cellular energy metabolism[J]. FEBS Open Bio, 2017, 7(2):284-292.
|
[18] |
FORETZ M, VIOLLET B. Regulation of hepatic metabolism by AMPK[J]. J Hepatol, 2011, 54(4):827-829.
|
[19] |
WANG Y, XU W B, YAN Z X, et al. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways[J]. J Exp Clin Cancer Res, 2018, 37:63.
|
[20] |
TANG X S, GU J H, SONG R L, et al. Osteoprotegerin inhibit osteoclast differentiation and bone resorption by enhancing autophagy via AMPK/mTOR/p70S6K signaling pathway in vitro[J]. J Cell Biochem, 2019, 120(2):1630-1642.
|
[21] |
KANG H, VIOLLET B, WU D Q. Genetic deletion of catalytic subunits of AMP-activated protein kinase increases osteoclasts and reduces bone mass in young adult mice[J]. J Biol Chem, 2013, 288(17):12187-12196.
|
[22] |
CAI Z Y, YANG B, SHI Y X, et al. High glucose downregulates the effects of autophagy on osteoclastogenesis via the AMPK/mTOR/ULK1 pathway[J]. Biochem Biophys Res Commun, 2018, 503(2):428-435.
|
[23] |
PIERREFITE-CARLE V, SANTUCCI-DARMANIN S, BREUIL V, et al. Autophagy in bone:self-eating to stay in balance[J]. Ageing Res Rev, 2015, 24:206-217.
|
[24] |
MIZUSHIMA N, KOMATSU M. Autophagy:renovation of cells and tissues[J]. Cell, 2011, 147(4):728-741.
|
[25] |
宋云珍. Olanzapine激活AMPK上调自噬减轻Rotenone对多巴胺能神经元的损伤[D]. 苏州:苏州大学, 2014.
|
|
SONG Y Z. Olanzapine protects against rotenone-induced injury on dopaminergic neurons via AMPK/autophagy pathway activation[D]. Suzhou:Suzhou University, 2014. (in Chinese)
|
[26] |
KIM M S, DAY C J, SELINGER C I, et al. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFκB ligand for bone resorption[J]. J Biol Chem, 2006, 281(2):1274-1285.
|
[27] |
NODA T. Regulation of autophagy through TORC1 and mTORC1[J]. Biomolecules, 2017, 7(3):52.
|
[28] |
CHUNG Y H, YOON S Y, CHOI B, et al. Microtubule-associated protein light chain 3 regulates Cdc42-dependent actin ring formation in osteoclast[J]. Int J Biochem Cell Biol, 2012, 44(6):989-997.
|
[29] |
KIM C J, SHIN S H, KIM B J, et al. The effects of kaempferol-inhibited autophagy on osteoclast formation[J]. In J Mol Sci, 2018, 19(1):125.
|